The Guardian: Japanese flu drug “clearly effective” in treating coronavirus, says China

24 March 2020
424 Views

Medical authorities in China have said a drug used in Japan to treat new strains of influenza appeared to be effective in coronavirus patients, Japanese media said on Wednesday.

Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.

“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters on Tuesday.

Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.

In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.

Source: The Guardian

You may be interested

Covid-19 Greece – 9 deaths in a day reported
GREECE
shares8 views
GREECE
shares8 views

Covid-19 Greece – 9 deaths in a day reported

makis - Sep 18, 2020

A total of 359 new cases of coronavirus in Greece were announced today, 36 of which were identified after checks…

Researchers untangle Crete’s oldest number system
GREECE
shares15 views
GREECE
shares15 views

Researchers untangle Crete’s oldest number system

Panos - Sep 18, 2020

According to a statement released by Elsevier, Silvia Ferrara of the University of Bologna and her colleagues conducted a new…

Chancellor Merkel and Italian PM Conte fully support Cyprus in light of Turkish provocations
GREECE
shares17 views
GREECE
shares17 views

Chancellor Merkel and Italian PM Conte fully support Cyprus in light of Turkish provocations

Panos - Sep 18, 2020

German Chancellor Angela Merkel and Italian Prime Minister Giuseppe Conte expressed their full support for the Republic of Cyprus and…

Leave a Comment

Your email address will not be published.